This award isn't about those other studies, it's about his choice to over-egg his research.

> Subsequent analysis of Raoult’s data found that his sample size was incredibly small, with only 6 patients given the hydroxychloroquine/azithromycin combination. The study was also found to be improperly controlled, and data was excluded for a number of patients whose condition worsened as they were either transferred to intensive care, or died. Subsequent studies have shown no clinical benefit for the use of hydroxychloroquine in patients with COVID-19.

> After Raoult’s study inspired a surge of interest in the use of hydroxychloroquine, [...]

His not very good research caused huge amounts of interest in hydroxychloroquine and distracted attention from other, far more beneficial, treatment.